Stock listing

Nextcure, Inc.

Selected listing: 2US0 · MUN · EUR · DE

Nextcure, Inc. (Munich:2US0), Health Technology. Latest release Aug 6, 2026: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

2US0:MUNEURDEUpdated October 2, 2026

Ticker: Munich:2US0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Nextcure, Inc.

NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

August 6, 2026

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

July 14, 2026

NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers

June 3, 2026

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

June 1, 2026

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results

May 7, 2026

All Nextcure, Inc. news →

Research Nextcure, Inc.

Nextcure, Inc. company profile

View the public company page for Nextcure, Inc. on 6ix.

Nextcure, Inc. news

Read company news and market updates connected to Nextcure, Inc..

Nextcure, Inc. investor events

Find investor webinars, events, and replay context for Nextcure, Inc..